| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $886.00K | $2.33M | $18.74M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $209.56M | $208.57M | $243.19M | $87.11M | $84.39M |
| R&D | $171.65M | $162.79M | $89.50M | $58.58M | $57.07M |
| SG&A | $47.91M | $45.78M | $39.95M | $28.53M | $27.32M |
| Operating Income | -$209.56M | -$208.57M | -$242.30M | -$84.78M | -$65.65M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$15.00K | $51.00K | -$26.00K | -$136.00K | $141.00K |
| Net Income | -$155.20M | -$208.02M | -$338.79M | -$83.81M | -$65.80M |
| EPS (basic) | – | – | 13.7600 | -0.9900 | -25.0200 |
| EPS (diluted) | – | – | 13.7600 | -0.9900 | -25.0200 |
| Shares (diluted) | – | – | $6.90M | $84.28M | $2.63M |